Affimed

Affimed CEO Adi Hoess Steps Down; Co to Cut Up to 50% of Workforce
Marketwatch
Mon, 01/8/24 - 11:43 am
Affimed
Adi Hoess
layoffs
restructuring
ASCO: Affimed pivots to cancer combo after failing to meet monotherapy study continuation criteria
Fierce Biotech
Mon, 06/5/23 - 10:20 am
Affimed
ASCO 2023
AFM24
Biopharma Layoff Tracker 2023: Rain Oncology, Takeda, PTC and more cut staff
BioSpace
Wed, 05/31/23 - 11:15 am
layoffs
Rain Oncology
Takeda
PTC Therapeutics
Affimed
Urovant Sciences
Roche
Novavax
Gossamer Bio
Bristol Myers Squibb
ADC Therapeutics
Affimed reveals 25% of staff were laid off in April in wake of phase 2 lymphoma fail
Fierce Biotech
Tue, 05/23/23 - 11:22 am
Affimed
layoffs
lymphoma
Affimed begins subject dosing in acute myeloid leukaemia therapy trial
Clinical Trials Arena
Thu, 03/30/23 - 10:12 am
Affimed
clinical trials
AFM283
AML
Ash 2022 preview – Affimed and Aptose score
EP Vantage
Sun, 11/6/22 - 01:24 pm
ASH 2022
Affimed
Aptose Biosciences
ADI-001
CAR-T
AFM13
AACR 2022 – A weekend of updates yields few winners
EP Vantage
Tue, 04/12/22 - 10:34 am
AACR
Bicycle Therapeutics
Rubius Therapeutics
C4 Therapeutics
Zentalis
Affimed
Seagen
Astellas
AACR 2022 – Affimed shows that 2021 was no fluke
EP Vantage
Mon, 04/11/22 - 10:26 am
AACR
Affimed
AFM13
natural killer cells
Affimed spurs promising response numbers in NK cell study, but durability will be the big question
Endpoints
Mon, 11/22/21 - 10:33 am
Affimed
natural killer cell therapy
lymphoma
2 Biotech Companies That Might Be on Pfizer's Radar Right Now
Motley Fool
Thu, 11/4/21 - 10:37 am
Pfizer
M&A
Adaptimmune Therapeutics
Affimed
AACR 2021 – Affimed wins, Oncternal loses
EP Vantage
Mon, 04/12/21 - 10:34 am
AACR
Affimed
AFM13
Oncternal
clinical trials
The Week Ahead In Biotech: Conferences, PDUFA Dates Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 06/16/19 - 05:41 pm
FDA
Merck
Arqule
Affimed
BeiGene
Epizyme
MorphoSys
Theravance
Allena Pharma
Akero Therapeutics
Atreca
Dermavant Sciences
Personalis
Prevail Therapeutics
Stoke Therapeutics
IPOs
Affimed scraps T-cell engager program, parts company with CSO
Fierce Biotech
Thu, 05/23/19 - 11:06 pm
Affimed
bispecific antibodies
T-cell engager
cancer
Affimed and Roche ink $5bn plus cancer immunotherapy deal
Pharmaforum
Tue, 08/28/18 - 10:03 am
Roche
Genentech
Affimed
cancer immunotherapy
drug development
These 5 Biotech Stocks Under $10 Are About to Break Out
TheStreet.com
Fri, 04/1/16 - 09:23 am
biotech
Ardelyx
Biocryst
Affimed
Adaptimmune
Sangamo BioSciences
Merck teams with Affimed on immuno-oncology combo
Fierce Biotech
Mon, 01/25/16 - 10:01 pm
Merck
Affimed
immuno-oncology